- Home
- ULS vs ASND Comparison
ULS vs ASND Comparison
Compare ULS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULS | ASND |
|---|---|---|
| Founded | 1894 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 12.8B |
| IPO Year | 2024 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ULS | ASND |
|---|---|---|
| Price | $79.00 | $213.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 15 |
| Target Price | $81.75 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 2.5M | 716.8K |
| Earning Date | 02-19-2026 | 02-11-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ 10.58 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $3,003,000,000.00 | $758,592,045.00 |
| Revenue This Year | $7.18 | $98.90 |
| Revenue Next Year | $5.56 | $83.74 |
| P/E Ratio | $47.22 | ★ N/A |
| Revenue Growth | 6.68 | ★ 97.46 |
| 52 Week Low | $48.54 | $118.03 |
| 52 Week High | $91.95 | $229.94 |
Technical Indicators
Market Signals| Indicator | ULS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 45.42 | 54.51 |
| Support Level | $78.49 | $207.28 |
| Resistance Level | $81.41 | $216.19 |
| Average True Range (ATR) | 1.64 | 8.21 |
| MACD | 0.23 | 0.51 |
| Stochastic Oscillator | 47.18 | 47.84 |
Price Performance
Historical ComparisonAbout ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.